NICE lipid modification guidance amended

Computer artwork of blood cells (round) in an artery affected by atherosclerosis. | SPL
Computer artwork of blood cells (round) in an artery affected by atherosclerosis. | SPL

The NICE Lipid Modification guideline (CG67) has been amended so that the Framingham risk equation is no longer the equation of choice for the assessment of cardiovascular disease (CVD) risk. The guideline now states that the QRISK or ASSIGN equations as well as the Framingham equation can be used to calculate the CVD risk. There are no changes to the categories of risk recommended for treatment or in whom the equations should be used to calculate the risk.

View MIMS summary of NICE Lipid Modification guideline

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Vitamin D3 Supplements

Formulations and indications of colecalciferol preparations.

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Treatment with febuxostat (Adenuric) should be avoided...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Colestid Orange. Use our constantly updated...

Updated bowel disease treatment summaries published by MIMS

Updated bowel disease treatment summaries published by MIMS

Updated quick-reference summaries of the latest NICE...